---

Novel positioning of Olea europaea L. (Olive) from farm to pharma indexed in pharmacopeia

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Afreen Usmani, Rania I.M. Almoselhy*

Volume : 6, Issue : 4, Year : 2023

Article Page : 161-170

https://doi.org/10.18231/j.ijnmhs.2023.027

Suggest article by email

Get Permission

Abstract

The current study explores the transformative journey of L. (Olive) from its traditional role in random traditional medicine to its current positioning in pharmacopeia as a pharmaceutical preparation with defined dosage and indications. The comprehensive examination covers botanical and chemical profiles, traditional uses, pharmacological activities, extraction techniques, quality control, regulatory status, clinical studies, and future directions. Various analytical methods, including spectroscopic and chromatographic approaches, are discussed for quality evaluation and detection of adulteration. Additionally, the regulatory landscape, particularly within the European Union, is outlined, emphasizing the importance of accurate labeling and geographical origin disclosure. The regulatory status of L. varies across regions, ranging from restrictions due to safety concerns to inclusion in pharmacopeias as traditional herbal medicine or pharmaceutical preparations. A pivotal development highlighted is the incorporation of Olive into Egyptian pharmacopeia, signifying a significant shift towards evidence-based therapy and reinforcing its acceptance in mainstream healthcare.

Keywords: Olea europaea L, Olive, Extra virgin olive oil, Olive leaf, Medicinal plants, Pharmacopeia, Herbal monograph, Egyptian Drug Authority (EDA), Traditional medicine, Therapeutic nutrition

How to cite : Usmani A, Almoselhy R I, Novel positioning of Olea europaea L. (Olive) from farm to pharma indexed in pharmacopeia. J Nutr Metab Health Sci 2023;6(4):161-170

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.